These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 20197747)

  • 21. Characterization of clinical response in patients with vitiligo undergoing autologous epidermal punch grafting.
    Feetham HJ; Chan JL; Pandya AG
    Dermatol Surg; 2012 Jan; 38(1):14-9. PubMed ID: 22093284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term follow-up study of segmental and focal vitiligo treated by autologous, noncultured melanocyte-keratinocyte cell transplantation.
    Mulekar SV
    Arch Dermatol; 2004 Oct; 140(10):1211-5. PubMed ID: 15492183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of stable vitiligo hands by ReCell system: a preliminary report.
    Cervelli V; Spallone D; Lucarini L; Palla L; Brinci L; De Angelis B
    Eur Rev Med Pharmacol Sci; 2010 Aug; 14(8):691-4. PubMed ID: 20707289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Punch grafting versus suction blister epidermal grafting in the treatment of stable lip vitiligo.
    Babu A; Thappa DM; Jaisankar TJ
    Dermatol Surg; 2008 Feb; 34(2):166-78; discussion 178. PubMed ID: 18093203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repigmentation of leucotrichia in vitiligo with noncultured cellular grafting.
    Gan EY; van Geel N; Goh BK
    Br J Dermatol; 2012 Jan; 166(1):196-9. PubMed ID: 21790525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Perspectives of surgical treatment of vitiligo].
    Trupar E; Brychta P
    Cas Lek Cesk; 2009; 148(3):129-31. PubMed ID: 19634273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of 1-mm minigrafts in treating vitiligo depends on patient age, disease site and vitiligo subtype.
    Kato H; Furuhashi T; Ito E; Kaneko N; Nakamura M; Watanabe S; Shintani Y; Maeda A; Yamaguchi Y; Morita A
    J Dermatol; 2011 Dec; 38(12):1140-5. PubMed ID: 21951328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ratio of size of recipient and donor areas in treatment of vitiligo by autologous cultured melanocyte transplantation.
    Hong WS; Hu DN; Qian GP; McCormick SA; Xu AE
    Br J Dermatol; 2011 Sep; 165(3):520-5. PubMed ID: 21564070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autologous noncultured melanocyte transplantation for stable vitiligo: can suspending autologous melanocytes in the patients' own serum improve repigmentation and patient satisfaction?
    Sahni K; Parsad D; Kanwar AJ; Mehta SD
    Dermatol Surg; 2011 Feb; 37(2):176-82. PubMed ID: 21269348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Melanocyte transplantation for the treatment of vitiligo: effects of different surgical techniques.
    Issa CM; Rehder J; Taube MB
    Eur J Dermatol; 2003; 13(1):34-9. PubMed ID: 12609779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stable vitiligo treated by a combination of low-dose oral pulse betamethasone and autologous, noncultured melanocyte-keratinocyte cell transplantation.
    Mulekar SV
    Dermatol Surg; 2006 Apr; 32(4):536-41. PubMed ID: 16681662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repigmentation in vitiligo patients. Melanocyte transfer via ultra-thin grafts.
    Kahn AM; Cohen MJ
    Dermatol Surg; 1998 Mar; 24(3):365-7. PubMed ID: 9537012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of vitiligo by transplantation of cultured pure melanocyte suspension: analysis of 120 cases.
    Chen YF; Yang PY; Hu DN; Kuo FS; Hung CS; Hung CM
    J Am Acad Dermatol; 2004 Jul; 51(1):68-74. PubMed ID: 15243526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of vitiligo on difficult-to-treat sites using autologous noncultured cellular grafting.
    Mulekar SV; Al Issa A; Al Eisa A
    Dermatol Surg; 2009 Jan; 35(1):66-71. PubMed ID: 19076191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinico-cellular stability of vitiligo in surgical repigmentation: an unexplored frontier.
    Lahiri K; Malakar S; Banerjee U; Sarma N
    Dermatology; 2004; 209(2):170-1. PubMed ID: 15316182
    [No Abstract]   [Full Text] [Related]  

  • 36. Repigmentation of skin and hairs in stable vitiligo by transplantation of autologous melanocytes in fibrin suspension.
    Hartmann A; Broecker EB; Hamm H
    J Eur Acad Dermatol Venereol; 2008 May; 22(5):624-6. PubMed ID: 18410624
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparative evaluation of the therapeutic efficacy of dermabrasion, dermabrasion combined with topical 5% 5-fluorouracil cream, and dermabrasion combined with topical placentrex gel in localized stable vitiligo.
    Sethi S; Mahajan BB; Gupta RR; Ohri A
    Int J Dermatol; 2007 Aug; 46(8):875-9. PubMed ID: 17651178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Standard guidelines of care for vitiligo surgery.
    Parsad D; Gupta S;
    Indian J Dermatol Venereol Leprol; 2008 Jan; 74 Suppl():S37-45. PubMed ID: 18688102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vitiligo treatment in childhood: a state of the art review.
    Tamesis ME; Morelli JG
    Pediatr Dermatol; 2010; 27(5):437-45. PubMed ID: 20553403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Update on skin repigmentation therapies in vitiligo.
    Falabella R; Barona MI
    Pigment Cell Melanoma Res; 2009 Feb; 22(1):42-65. PubMed ID: 19040503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.